Computer-Delivered Therapy for Anxiety and Alcohol Use Disorder

This study is testing if a computer-delivered program called Negative Emotions and Addiction Tools Program (NEAT) can help people who have both an anxiety disorder (like generalized anxiety disorder, panic disorder, or social anxiety disorder) and an alcohol use disorder. The NEAT program uses cognitive behavioral therapy (CBT), which helps you understand and change your thoughts and behaviors. It also includes Progressive Muscle Relaxation Training (PMRT) to help with stress. Researchers want to see if this computer program can reduce heavy drinking days and help people stay sober longer. You might be able to join if you are between 18 and 65 years old and have a recent diagnosis of one of these anxiety disorders and are primarily seeking treatment for alcohol use. The study aims to enroll 256 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It is a randomized controlled trial, comparing the computer-delivered therapy to standard alcohol use disorder treatment.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track your progress for eight months after treatment, with a primary assessment at four months, to see how well the treatment worked.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05117255

Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity

Recruiting
NAAges 18–65InterventionalTreatment
University of Minnesota
~256 participants
Updated 2025-12-17 on ClinicalTrials.gov
What's tested:Negative Emotions and Addiction Tools Program (NEAT)- Cognitive Behavioral TherapyProgressive Muscle Relaxation Training (PMRT)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent heavy ("binge") days drinking
Measured over eight-months following treatment (four-month assessment is primary)
+1 more outcome measured
Generalized Anxiety Disorder
Panic Disorder
Social Anxiety Disorder
Alcohol Use Disorder
Depression
1 sites across 1 states
Minnesota1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

current (past 30 days) Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) diagnosis of panic disorder with or without agoraphobia (PD/Ag), generalized anxiety disorder (GAD) or social anxiety disorder (SAD)
receiving treatment primarily for alcohol (vs. drug) dependence
ability to provide informed consent
a minimum of an eighth grade English reading level
status as a residential patient in the Lodging Plus (LP) addiction treatment program
sufficient time left in their residential LP care to complete the study protocol through the post-treatment assessment

Exclusion

cognitive or medical impairments that prohibit study participation as determined by study PI
serious suicide risk determined by study PI
court-ordered treatment. (The exclusion is based on its classification as a "vulnerable" population.)
Self-reported past participation in a Kushner intervention study while in Lodging Plus
  • Percent heavy ("binge") days drinkingeight-months following treatment (four-month assessment is primary)

    a ratio expressed as a percent of the days the individual drank 5 (for men) or 4 (for women) or more drinks to the total number of days over the follow-up period in which drinking was possible.

  • Days to first useeight-months following treatment (four-month assessment is primary)

    Determined for the entirety of the post treatment time for which the investigators have data up to the 8-month assessment.